Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

ENDRA Life Sciences (NDRA) Other Gross PP&E Adjustments (2016 - 2025)

ENDRA Life Sciences has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$616847.0 for Q4 2021.

  • Quarterly Other Gross PP&E Adjustments fell 511.0% to -$616847.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$616847.0 through Dec 2021, down 511.0% year-over-year, with the annual reading at -$616847.0 for FY2021, 511.0% down from the prior year.
  • Other Gross PP&E Adjustments was -$616847.0 for Q4 2021 at ENDRA Life Sciences, down from -$551614.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $684418.0 in Q1 2019 and troughed at -$616847.0 in Q4 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $484328.5 (2017), against an average of $256602.2.
  • The largest YoY upside for Other Gross PP&E Adjustments was 34.5% in 2021 against a maximum downside of 511.0% in 2021.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $579179.0 in 2017, then rose by 10.24% to $638508.0 in 2018, then tumbled by 63.87% to $230664.0 in 2019, then crashed by 34.93% to $150083.0 in 2020, then plummeted by 511.0% to -$616847.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Other Gross PP&E Adjustments are -$616847.0 (Q4 2021), -$551614.0 (Q3 2021), and -$583296.0 (Q2 2021).